Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

What is Genetic Engineering?00:49

What is Genetic Engineering?

75.4K
Overview
75.4K
Transduction01:16

Transduction

98
Among the three main modes of HGT—transformation, conjugation, and transduction—transduction is unique in that it is mediated by bacteriophages, or bacterial viruses.Transduction occurs in two ways. Generalized transduction occurs during the lytic cycle of a bacteriophage infection. In this process, bacteriophages infect bacterial cells, replicate within them, and ultimately cause cell lysis, releasing newly assembled virions. Occasionally, random fragments of the bacterial genome...
98

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

One-Pot Tandem Construction of Isoindolinone Derivatives under Visible-Light Photoredox Catalysis.

ACS omega·2026
Same author

Fungal Biotechnology and Application 3.0.

Journal of fungi (Basel, Switzerland)·2026
Same author

Unhealthy dietary patterns and Alzheimer's disease: associations and underlying mechanistic pathways.

Critical reviews in food science and nutrition·2026
Same author

Targeting RNA quality-control defects in tauopathies: Pharmacodynamic biomarkers and therapeutic development.

Pharmacological research·2026
Same author

Green extraction of RuBisCO-rich leaf protein for sustainable food systems: process efficiency, functional quality, and sustainability assessment.

Food chemistry·2026
Same author

Anti-obesity mechanisms of adzuki bean saponin: a multi-omics and experimental study.

NPJ science of food·2026

相关实验视频

Updated: Sep 9, 2025

QTL Mapping and CRISPR/Cas9 Editing to Identify a Drug Resistance Gene in Toxoplasma gondii
11:37

QTL Mapping and CRISPR/Cas9 Editing to Identify a Drug Resistance Gene in Toxoplasma gondii

Published on: June 22, 2017

16.4K

基因改造增加了克雷桑托米产量和神经保护能力

Wei Ye1, Wenkang Ye2, Xin Huang2

  • 1Southern Marine Science and Engineering Guangdong Laboratory (Guangzhou), Guangzhou 511458, China; Department of Ocean Science and Hong Kong Branch of Southern Marine Science and Engineering Guangdong Laboratory (Guangzhou), The Hong Kong University of Science and Technology, Hong Kong 999077, China; Hubei Province Biological Yeast Engineering Technology Research Center, Hubei Key Laboratory of Natural Products Research and Development, School of Biological & Pharmaceutical Sciences of China Three Gorges University, Yichang 443000, China.

Journal of advanced research
|September 3, 2025
PubMed
概括

研究人员阐明了crexanthomycins的生物合成,提高了它们的产量. 一种新的衍生物,crexanthomycin G,显示强大的神经保护作用对粉样β聚合和记忆衰退.

关键词:
生物合成逻辑克雷克桑托米辛遗传修饰代谢工程神经保护作用

更多相关视频

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
09:44

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Published on: May 2, 2025

307
Conditional Genetic Transsynaptic Tracing in the Embryonic Mouse Brain
11:03

Conditional Genetic Transsynaptic Tracing in the Embryonic Mouse Brain

Published on: December 22, 2014

18.8K

相关实验视频

Last Updated: Sep 9, 2025

QTL Mapping and CRISPR/Cas9 Editing to Identify a Drug Resistance Gene in Toxoplasma gondii
11:37

QTL Mapping and CRISPR/Cas9 Editing to Identify a Drug Resistance Gene in Toxoplasma gondii

Published on: June 22, 2017

16.4K
Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
09:44

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Published on: May 2, 2025

307
Conditional Genetic Transsynaptic Tracing in the Embryonic Mouse Brain
11:03

Conditional Genetic Transsynaptic Tracing in the Embryonic Mouse Brain

Published on: December 22, 2014

18.8K

科学领域:

  • 自然产品生物合成
  • 神经药理学

背景情况:

  • 克雷克桑托米是一种五角多,已被证明具有神经保护性.
  • 克雷克桑托米的低产量限制了它们的治疗用途.

研究的目的:

  • 阐明了克雷克桑托米的生物合成途径.
  • 加强大规模的克雷桑托米生产.
  • 发现具有改善神经保护功能的新衍生药物.

主要方法:

  • chr基因群的异质表达.
  • 调节基因的基因操纵 (淘汰/过度表达).
  • 在体外生化测定和酶功能探索 (ChrN,UGT50).
  • 在Caenorhabditis elegans模型中进行神经保护评估.

主要成果:

  • 克雷克桑托米的生物合成途径得到了阐明.
  • 在工程化Streptomyces chrestomyceticus中产量增加了10倍以上.
  • 鉴定出具有显著的神经保护作用的新衍生物克雷桑托米辛G.
  • 克雷桑托米辛G可以缓解粉素β诱导的氧化应激,抑制聚合,并改善C. elegans的记忆力.

结论:

  • 这项研究提供了关于crexanthomycin生物合成和神经保护机制的重要见解.
  • 这些发现为开发神经退行性疾病的治疗方法奠定了基础.